An enhanced model that integrates non-AJCC clinical features provides clinicians with a more accurate tool for identifying high-risk patients with MCC.

Oral squamous cell cancer, or OSCC, arises in the cells that line the mouth. The disease is often diagnosed at a late stage, ...

According to the AJCC, there are two definitions of stage II oral cancer ... making it harder to detect earlier signs. But ...

Anti-PD1 immunotherapy improves outcomes for patients with metastatic cutaneous squamous cell carcinoma (cSCC). But we need to know more about who will, or will not, respond adequately.

Anti-PD1 immunotherapy improves outcomes for patients with metastatic cutaneous squamous cell carcinoma (cSCC). But we need to know more about who will, or will not, respond adequately.